Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Flowtech wins upgrade contract for Ireland's Rice Bridge

(Sharecast News) - Flowtech Fluidpower announced on Wednesday that it has won a €4.5m contract to upgrade Rice Bridge in Waterford City, the Republic of Ireland, with work focused on modernising the bridge's mechanical and electrical systems. The AIM-traded firm said the 15-month rehabilitation project would be followed by a further 12-month period to address any remaining issues.

It said the contract, officially signed on 13 June in the presence of government ministers and local officials, would involve the overhaul of the bridge's 'MEICA' systems - mechanical, electrical, instrumentation, control and automation.

The infrastructure, first opened in 1984, is a key transport link in the region, serving commercial traffic, public transport and emergency services.

Funding for the project was being provided under Ireland's Strategic Grant scheme for local and regional roads, with an initial €1.5m allocated for 2025.

"This crucial rehabilitation project is a proud moment for everyone in Flowtech," said chief executive officer Mike England.

"Our extensive experience in bridge design and repair makes Flowtech the perfect match for this project, and I look forward to seeing what our superb engineering teams can accomplish over the next two years."

At 1356 BST, shares in Flowtech Fluidpower were up 4.82% at 65.2p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.